360 related articles for article (PubMed ID: 21670092)
1. Age-related medical decision limits for urinary free (unconjugated) metadrenalines, catecholamines and metabolites in random urine specimens from children.
Davidson DF; Hammond PJ; Murphy D; Carachi R
Ann Clin Biochem; 2011 Jul; 48(Pt 4):358-66. PubMed ID: 21670092
[TBL] [Abstract][Full Text] [Related]
2. Reference intervals for urinary catecholamines and metabolites from birth to adulthood.
Pussard E; Neveux M; Guigueno N
Clin Biochem; 2009 Apr; 42(6):536-9. PubMed ID: 19027729
[TBL] [Abstract][Full Text] [Related]
3. [Sensitivity and specificity of the determination of urinary catecholamines and their acid metabolites in the diagnosis of neuroblastoma in children].
Horsmans Y; Desager JP; Harvengt C
Bull Cancer; 1990; 77(10):985-9. PubMed ID: 2249018
[TBL] [Abstract][Full Text] [Related]
4. Conjugated versus "free" acidic metabolites of catecholamines in random urine samples: significance for the diagnosis of neuroblastoma.
Tuchman M; Stoeckeler JS
Pediatr Res; 1988 Jun; 23(6):576-9. PubMed ID: 3393388
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic and prognostic impact of urinary catecholamines in neuroblastoma patients.
Strenger V; Kerbl R; Dornbusch HJ; Ladenstein R; Ambros PF; Ambros IM; Urban C
Pediatr Blood Cancer; 2007 May; 48(5):504-9. PubMed ID: 16732582
[TBL] [Abstract][Full Text] [Related]
6. Methylated catecholamine metabolites for diagnosis of neuroblastoma.
Candito M; Thyss A; Albertini M; Deville A; Politano S; Mariani R; Chambon P
Med Pediatr Oncol; 1992; 20(3):215-20. PubMed ID: 1574031
[TBL] [Abstract][Full Text] [Related]
7. Value of random urinary homovanillic acid and vanillylmandelic acid levels in the diagnosis and management of patients with neuroblastoma: comparison with 24-hour urine collections.
Tuchman M; Morris CL; Ramnaraine ML; Bowers LD; Krivit W
Pediatrics; 1985 Feb; 75(2):324-8. PubMed ID: 3969335
[TBL] [Abstract][Full Text] [Related]
8. Excretion of catecholamines in relatives of patients with familial neuroblastoma.
Piöchl E; Käser H; Klein H
Cancer Res; 1976 Jan; 36(1):10-12. PubMed ID: 1247989
[TBL] [Abstract][Full Text] [Related]
9. Changes in urinary excretion of catecholamines and their metabolites in pediatric dental patients.
Sakuma N; Nagasaka N
ASDC J Dent Child; 1996; 63(2):118-22. PubMed ID: 8708120
[TBL] [Abstract][Full Text] [Related]
10. Vanillylmandelic acid, homovanillic acid, and catecholamines in urine of infants with neuroblastoma 6- to 11-month-old.
Nishi M; Miyake H; Takeda T; Takasugi N; Sato Y; Hanai J
Jpn J Clin Oncol; 1986 Dec; 16(4):351-5. PubMed ID: 3795531
[TBL] [Abstract][Full Text] [Related]
11. [Biochemical diagnosis of pheochromocytoma and neuroblastomas].
Candito M; Billaud E; Chauffert M; Cottet-Emard JM; Desmoulin D; Garnier JP; Greffe J; Hirth C; Jacob N; Millot F; Nignan A; Patricot MC; Peyrin L; Plouin PF
Ann Biol Clin (Paris); 2002; 60(1):15-36. PubMed ID: 11830391
[TBL] [Abstract][Full Text] [Related]
12. Parkinson's disease: the effect of L-dopa therapy on urinary free catecholamines and metabolites.
Davidson DF; Grosset K; Grosset D
Ann Clin Biochem; 2007 Jul; 44(Pt 4):364-8. PubMed ID: 17594783
[TBL] [Abstract][Full Text] [Related]
13. Clinical validation of urine 3-methoxytyramine as a biomarker of neuroblastoma and comparison with other catecholamine-related biomarkers.
Lam L; Woollard GA; Teague L; Davidson JS
Ann Clin Biochem; 2017 Mar; 54(2):264-272. PubMed ID: 27235704
[TBL] [Abstract][Full Text] [Related]
14. Development of a new biochemical test to diagnose and monitor neuroblastoma in Vietnam: homovanillic and vanillylmandelic acid by gas chromatography-mass spectrometry.
Tran MT; Baglin J; Tran TT; Hoang KT; Phung LT; Read A; Greaves RF
Clin Biochem; 2014 Feb; 47(3):206-15. PubMed ID: 24296288
[TBL] [Abstract][Full Text] [Related]
15. Paracetamol-associated interference in an HPLC-ECD assay for urinary free metadrenalines and catecholamines.
Davidson FD
Ann Clin Biochem; 2004 Jul; 41(Pt 4):316-20. PubMed ID: 15298744
[TBL] [Abstract][Full Text] [Related]
16. Urinary excretion of methylated catecholamine metabolites in a child with neuroblastoma maturing into ganglioneuroma.
Candito M; Soler C; Deville A; Bekri S; Chambon P; Thyss A
Med Pediatr Oncol; 1996 Jan; 26(1):57-60. PubMed ID: 7494513
[TBL] [Abstract][Full Text] [Related]
17. Initial urinary catecholamine metabolite concentrations and prognosis in neuroblastoma.
Laug WE; Siegel SE; Shaw KN; Landing B; Baptista J; Gutenstein M
Pediatrics; 1978 Jul; 62(1):77-83. PubMed ID: 683787
[TBL] [Abstract][Full Text] [Related]
18. Three years of experience with random urinary homovanillic and vanillylmandelic acid levels in the diagnosis of neuroblastoma.
Tuchman M; Ramnaraine ML; Woods WG; Krivit W
Pediatrics; 1987 Feb; 79(2):203-5. PubMed ID: 3808793
[TBL] [Abstract][Full Text] [Related]
19. Elevation of urinary catecholamines and their metabolites following tyrosine administration in humans.
Alonso R; Gibson CJ; Wurtman RJ; Agharanya JC; Prieto L
Biol Psychiatry; 1982 Jul; 17(7):781-90. PubMed ID: 7115832
[TBL] [Abstract][Full Text] [Related]
20. Urinary VMA, dopamine and the likelihood of neuroblastoma: a preferred way of reporting laboratory results?
Sies CW; Florkowski CM; Sullivan M; Mackay R; George PM
Ann Clin Biochem; 2006 Jul; 43(Pt 4):300-5. PubMed ID: 16824281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]